CAT No: CP26330
CAS No:135592-13-1
Synonyms/Alias:135592-13-1;(R)-2-((tert-Butoxycarbonyl)amino)-3-methyl-3-(tritylthio)butanoicacid;Boc-S-trityl-L-penicillamine;C29H33NO4S;BOC-PEN(TRT)-OH;SCHEMBL4864593;L-Valine,N-[(1,1-dimethylethoxy)carbonyl]-3-[(triphenylmethyl)thio]-;CTK4B9891;GFULWLRDJMLHCD-XMMPIXPASA-N;MolPort-006-705-756;6355AA;ANW-55727;Boc-beta,beta-dimethyl-Cys(Trt)-OH;ZINC15721701;AKOS015836586;AKOS015894448;RTR-004788;AJ-67838;AK-58429;KB-209683;N-t-butoxycarbonyl-S-trityl-L-penicillamine;TR-004788;K-4319;I05-1008;(2R)-2-[(tert-butoxycarbonyl)amino]-3-methyl-3-[(triphenylmethyl)sulfanyl]butanoicacid
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.